Dual Role of IL-12 in Early and Late Stages of Murine Collagen Type II Arthritis

Journal of Immunology

Volumn 159, Issue 8, 1997, Pages 4094-4102

  Joosten, Leo A B ^a   Lubberts, Erik ^a   Helsen, Monique M A ^a   Van Den Berg, Wim B ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; COLLAGEN; INTERLEUKIN 10; INTERLEUKIN 12; RECOMBINANT PROTEIN;

ANIMAL; ARTHRITIS; ARTICLE; BLOOD; CATTLE; DBA MOUSE; FEMALE; IMMUNOLOGY; MALE; MOUSE; PATHOLOGY; PHYSIOLOGY; TIME;

ANIMALS; ANTIBODIES; ARTHRITIS, EXPERIMENTAL; CATTLE; COLLAGEN; FEMALE; INTERLEUKIN-10; INTERLEUKIN-12; MALE; MICE; MICE, INBRED DBA; RECOMBINANT PROTEINS; TIME FACTORS;

EID: 0031572430     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Kobayashi, M., L. Fitz, M. Ryan, R. M. Hewick, S. C. Clark, S. H. Chan, R. Loudon, F. Sherman, B. Perussia, and G. Trinchieri. 1989. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J. Exp. Med. 170:827.
2. Stern, A. S., F. J. Podlaski, J. D. Hulmes, E. Y. Pan, P. M. Quinn, A. G. Wolitzky, P. C. Familletti, D. L. Stremlo, T. Truitt, R. Chizzonite, and M. K. Gately. 1990. Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells. Proc. Natl. Acad. Sci. USA 87:6808.
3. Wolf, S. F., P. A. Temple, M. Kobayashi, D. Young, M. Dicig, L. Lowe, R. Dzialo, L. Fitz, C. Ferenz, R. M. Hewick, K. Kelleher, S. H. Hermann, S. C. Clark, L. Azzoni, S. H. Chan, G. Trinchieri, and B. Perussia. 1991. Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells. J. Immunol. 146:3074.
4. Scott, P. 1993. IL-12: initiation cytokine for cell-mediated immunity. Science 260:496.
5. + T-cells to enhance priming for interferon-γ production and diminished interleukin-4 inhibition of such priming. Proc. Natl. Acad. Sci. USA 90:10188.
6. Manetti, R., P. Parronchi, M. G. Guidizi, M. P. Piccinni, E. Maggi, G. Trinchieri, and S. Romagnani. 1993. Natural killer cell stimulatory factor (IL-12) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4 producing cells. J. Exp. Med. 177:1199.
7. Abbas, A. K., K. M. Murphy, and A. Sher. 1996. Functional diversity of helper T lymphocytes. Nature 383:787.
8. D'Andrea, A., M. Rengaraju, N. M. Valiante, J. Chehimi, M. Kubin, M. Aste, S. H. Chan, M. Kobayashi, D. Young, E. Nickbarg, R. Chizzonite, S. F. Wolf, and G. Trinchieri. 1992. Production of natural killer cell stimulatory factor (interleukin-12) by peripheral blood mononuclear cells. J. Exp. Med. 176:1387.
9. Gazzinelli, R. T., S. Hieny, T. A. Wynn, S. F. Wolf, and A. Sher. 1993. IL-12 is required for the T-lymphocyte-independent induction of interferon-gamma by an intracellular parasite and induces resistance in T-cell-deficient hosts. Proc. Natl. Acad. Sci. USA 90:6115.
10. + T cells during initiation of infection. J. Exp. Med. 179:447.
11. Wysocka, M., M. Kubin, L. Q. Vieira, L. Ozmen, G. Garotta, P. Scott, and G. Trinchieri. 1995. Interleukin-12 is required for interferon-γ production and lethality in lipopolysaccharide-induced shock in mice. Eur. J. Immunol. 25:672.
12. Ozmen, L., M. Pericin, J. Hakimi, R. A. Chizzonite, M. Wysocka, G. Trinchieri, G. Gately, and G. Garotta. 1994. Interleukin-12, interferon gamma and tumor necrosis factor alpha are the key cytokines of the generalized Shwartzman reaction. J. Exp. Med. 180:907.
13. Trinchieri, G. 1995. IL-12: a proinflammatory cytokine with immunoregulatory functions that bridges innate resistance and antigen specific adaptive immunity. Annu. Rev. Immunol. 13:251.
14. Segal, B. M., and E. M. Shevach. 1996. IL-12 unmasks latent autoimmune disease in resistant mice. J. Exp. Med. 184:771.
15. Gavett, S. H., D. J. O'Hearn, X. Li, S. K. Huang, F. D. Finkelman, and M. Wills-Karp. 1995. IL-12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice. J. Exp. Med. 182: 1527.
16. Chensue, S. W., J. H. Ruth, K. Warmington, P. Lincoln, and S. L. Kunkel. 1995. In vivo regulation of macrophage IL-12 production during type 1 and type 2 cytokine-mediated granuloma formation. J. Immunol. 155:3546.
17. + T lymphocytes. J. Immunol. 155:111.
18. Daftarian, P. M., A. Kumar, M. Kryworuchko, and F. Diaz-Mitoma. 1996. IL-10 production is enhanced in human T cells by IL-12 and IL-6 and in monocytes by TNF-α. J. Immunol. 157:12.
19. Meyaard, L., E. Hovenkamp, S. A. Otto, and F. Miedema. 1996. IL-12 induced IL-10 production by human T cell as a negative feedback for IL-12-induced immune responses. J. Immunol. 156:2776.
20. Jeannin, P., Y. Delneste, M. Seveso, P. Life, and J. Y. Bonnefoy. 1996. IL-12 synergizes with IL-2 and other stimuli in inducing IL-10 production by human T cells. J. Immunol. 156:3159.
21. D'Andrea, A., X. Ma, M. Asta-Amezaga, C. Paganin, and G. Trinchieri. 1995. Stimulatory and inhibitory effects of IL-4 and IL-13 on production of cytokines by human peripheral blood mononuclear cells: priming for IL-12 and TNFα production. J. Exp. Med. 181:537.
22. Trentham, D. E., A. S. Townes, and A. H. Kang. 1977. Autoimmunity to type II collagen: an experimental model of arthritis. J. Exp. Med. 146:857.
23. Courtenay, J. S., M. J. Dallman, A,. B. Dayan, A. Martin, and B. Mosedale. 1980. Immunization against heterologous type II collagen-induced arthritis in mice. Nature 2843:666.
24. Stuart, J. M., A. S. Townes, and A. H. Kang. 1982. Nature and specificity of immune responses to collagen in type II collagen-induced arthritis in mice. J. Clin. Invest. 69:673.
25. Killar, L. M., and C. J. Dunn. 1989. IL-1 potentiates the development of collagen induced arthritis in mice. Clin Sci. 76:535.
26. Van den Berg, W. B., L. A. B. Joosten, M. M. A. Helsen, A. A. J van de Loo. 1994. Amelioration of established murine collagen induced arthritis with anti-IL-1 treatment. Clin. Exp. Immunol. 95:237.
27. Joosten, L. A. B., M. M. A. Helsen, A. J. J. van de Loo, and W. B. van den Berg. 1996. Anti-cytokine treatment of established collagen type II arthritis in DBA/1 mice: a comparative study using anti-IL-1 alpha, beta and IL-IRa. Arthritis Rheum. 39:797.
28. Bakker, A. C., L. A. B. Joosten, O. J. Arntz, M. M. A. Helsen, A. Bendele, A. A. J. van de Loo, and W. B. van den Berg. 1997. Prevention of murine collagen induced arthritis in the knee and ipsilateral paw by local expression of human IL-1ra protein in the knee. Arthritis Rheum. 40:893,
29. Joosten, L. A. B., E. Lubberts, P. Durez, M. M. A. Helsen, M. J. Jacobs, M. Goldman, and W. B. van den Berg. 1997. Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis: protective effect of interleukin-4 and interleukin-10 treatment on cartilage destruction. Arthritis Rheum. 40:249.
30. Germann, T., J. Szeliga, H. Hess, S. Storkel, F. J. Podlaski, M. K. Gately, E. Schmitt, and E. Rude. 1995. Administration of interleukin-12 in combination of with type II collagen induces severe arthritis in DBA/1 mice. Proc. Natl. Acad. Sci. USA 92:4823.
31. Hess, H., M. K. Gately, E. Rude, E. Schmitt, J. Szeliga, and T. Germann. 1996. High doses of interleukin-12 inhibited the development of joint disease in DBA-1 mice immunized with type II collagen in complete Freund's adjuvant. Eur. J. Immunol. 26:187.
32. Caccese, R. G., J. L. Zimmerman, and R. P. Carlson. 1992. Bacterial lipopolysaccharide potentiates type II collagen-induced arthritis in mice. Mediat. Inflam. 1:273.
33. Joosten, L. A. B., M. M. A. Helsen, and W. B. van den Berg. 1994. Accelerated onset of collagen-induced arthritis by remote inflammation. Clin. Exp. Immunol. 97:204.
34. Buchanan, J. M., L. A. Vogel, V. H. Van Cleave, and D. W. Metzger. 1995. Interleukin 12 alters the isotype-restricted antibody response of mice to hen egg-white lysozyme. Int. Immunol. 7:1519.
35. Ishida, H., T. Muchamuel, S. Sakaguchi, S. Andrade, S. Menon, and M. Howard. 1994. Continuous administration of anti-interleukin-10 antibodies delays the onset of autoimmunity in NZB/W F1 mice. J. Exp. Med. 179:305.
36. Van den Berg, W. B., L. A. B. Joosten, and L. B. A. van de Putte. 1982. Electrical charge of the antigen determines intraarticular handling and chronicity of arthritis in mice. J. Clin. Invest. 74:1850.
37. Van Meurs, J. B. J., P. L. E. M. van Lent, L. A. B. Joosten, P. M. van de Kraan, and W. B. van den Berg. 1997. Quantification of mRNA levels in joint capsule and articular cartilage on the murine knee joint by RT-PCR. Rheum. Int. 16:197.
38. Chomczynski, P., and N. Sacchi. 1987. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156.
39. Kanangat, S., P. Blair, R. Reddy, M. Deheshia, V. Godfrey, B. T. Rose, and E. Wilkinson. 1996. Disease in the scurfy (sf) mouse is associated with overexpression of cytokine genes. Eur. J. Immunol. 26:161.
40. Tare, N. S., S. Bowen, R. R. Warrier, D. M. Carvajal, W. R. Benjamin, J. H. Riley, T. D. Anderson, and M. K. Gately. 1995. Administration of recombinant interleukin-12 to mice suppresses hematopoiesis in the bone marrow but enhances hematopoiesis in the spleen. J. Interferon Cytokine Res. 15:377.
41. Mauri, C., R. O. Williams, M. Walmsley, and M. Feldmann. 1996. Relationship between Th1/Th2 cytokine patterns and the arthritogenic response in collagen-induced arthritis. Eur. J. Immunol. 26:1511.
42. Szeliga, J., H. Hess, E. Rude, E. Schmitt, and T. Germann. 1996. IL-12 promotes cellular but not humoral type II collagen-specific Th1-type responses in C57B1/6 and B10. Q mice and fails to induce arthritis. Int. Immunol. 8:1221.
43. van Lent, P. L. E. M., A. A. J. van de Loo, A. E. M. Holthuysen, L. A. M. van de Bersselaar, H. Vermeer, and W. B. van den Berg. 1995. Major role for IL-1 and not TNF in early cartilage damage in immune complex arthritis in mice. J. Rheumatol. 22:2250.
44. Williams, R. O., M. Feldmann, and R. N. Maini. 1992. Anti-TNF ameliorates joint disease in murine collagen induced arthritis. Proc. Natl. Acad. Sci. USA 89:9784.
45. Leonard, J. P., K. E. Waldburger, and S. J. Goldman. 1995. Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin-12. J. Exp. Med. 181:381.
46. Trembleau, S., G. Penna, E. Bosi, A. Mortara, G. K. Gately, and L. Adorini. 1995. Interleukin-12 administration induces T helper type 1 cells and accelerates autoimmune diabetes in NOD mice. J. Exp. Med. 181:817.
47. Neurath, M. F., I. Fuss, B. L. Kelsall, E. Struber, and W. Strober. 1995. Antibodies to interleukin-12 abrogate established experimental colitis in mice. J. Exp. Med. 182:1281.
48. Duchmann, R., E. Schmitt, P. Knolle, K. H. Meyer zum Buschenfelde, and M. Neurath. 1996. Tolerance towards resident intestinal flora in mice is abrogated in experimental colitis and restored by treatment with IL-10 or antibodies to IL-12. Eur. J. Immunol. 26:934.
49. Huang, F. P., G. J. Feng, G. Lindop, D. I. Stott, and P. Y. Liew. 1996. The role of IL-12 and nitric oxide in the development of spontaneous autoimmune disease in MRL/MP-lpr/lpr mice. J. Exp. Med. 183:1447.
50. Walmsley, M., P. D. Katsikis, E. Abney, S. Parry, R. O. Williams, R. N. Maini, and M. Feldmann. 1996. IL-10 inhibition of the progression of established collagen induced arthritis. Arthritis Rheum. 39:495.
51. Bliss, J., V. van Cleave, K. Murray, A. Wiencis, M. Ketchum, R. Maylor, T. Haire, C. Resmini, A. K. Abbas, and S. F. Wolf. 1996. IL-12, as an adjuvant, promotes a T helper 1 cell, but does not suppress a T helper 2 cell recall response. J. Immunol 156:887.
52. Wynn, T. A., D. Jankovic, S. Hieny, K. Zioncheck, P. Jardieu, A. W. Cheever, and A. Sher. 1995. IL-12 exacerbates rather than suppresses T helper 2-dependent pathology in the absence of endogenous IFN-γ. J. Immunol. 154:3999.
53. Arend, W. P., and J.-M. Dayer. 1995. Inhibition of the production and effects of interleukin-1 and tumor necrosis factor a in rheumatoid arthritis. Arthritis Rheum. 38:151.
54. Campion, G. V., M. E. Lesback, J. Lookabaugh, G. Gordon, M. Catalano, and The IL-I-Ra Arthritis Study Group. 1996. Dose-range and dose-frequency study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis. Arthritis Rheum. 39:1092.
55. Bucht, A., P. Larsson, L. Weisbrot, C. Thorne, P. Pisa, G. Smedegard. E. C. Keystone, and A. Gronberg. 1996. Expression of interferon-gamma (IFN-γ), IL-10, IL-12 and transforming growth factor-beta (TGF-β) mRNA in synovial fluid cells from patients in the early phase and late phases of rheumatoid arthritis (RA). Clin. Exp. Immunol. 103:357.
56. Anguita, J., D. H. Persing, M. Rincon, S. W. Barthold, and E. Fikrig. 1996. Effect of anti-IL-12 treatment on murine Lyme borreliosis. J. Clin. Invest. 97:1028.
57. Uyemura, K., L. L. Demer, S. C. Castle, D. Jullien, J. A. Berliner, M. K. Gately, R. R. Warrier, N. Pham, A. M. Fogelman, and R. L. Modlin. 1996. Cross-regulatory roles of IL-12 and IL-10 in atherosclerosis. J. Clin. Invest. 97:2130.